964
Views
35
CrossRef citations to date
0
Altmetric
Original Article

Aerobic physical activity improves endothelial function in the middle-aged patients with erectile dysfunction

, , , &
Pages 265-272 | Received 17 Aug 2010, Accepted 27 Nov 2010, Published online: 24 Nov 2011

Figures & data

Table I. Protocol of aerobic physical activity and Mediterranean diet's principles observed by patients during the study.

Figure 1. Representative flow cytometric scattergrams showing the gating strategy used. Upper panels, after PhA standard aerobic protocol in patients with ED; lower panels, before PhA aerobic protocol. Both histograms 1 report the forward versus side scatter dot plot: three different cell populations can be identified (gate F: lymphocytes; gate I: monocytes; gate J: polymorphonuclear cells). Both histograms 2 report the CD45pos (E) and CD45neg (G) cells. Both histograms 3 report only the CD45neg cells (gate G) subdivided according to the expression of CD34 and CD144 antigen staining. EPCs were defined as CD45neg/CD34pos/CD144pos, whereas EMP CD45neg/CD34neg/CD144pos.

Figure 1. Representative flow cytometric scattergrams showing the gating strategy used. Upper panels, after PhA standard aerobic protocol in patients with ED; lower panels, before PhA aerobic protocol. Both histograms 1 report the forward versus side scatter dot plot: three different cell populations can be identified (gate F: lymphocytes; gate I: monocytes; gate J: polymorphonuclear cells). Both histograms 2 report the CD45pos (E) and CD45neg (G) cells. Both histograms 3 report only the CD45neg cells (gate G) subdivided according to the expression of CD34 and CD144 antigen staining. EPCs were defined as CD45neg/CD34pos/CD144pos, whereas EMP CD45neg/CD34neg/CD144pos.

Table II. Penile dynamic echo-color doppler parameters, IIEF-5 score and metabolic features (mean ± SEM) of the patients (group A and group B) with arterial erectile dysfunction at baseline and after three months of standard aerobic protocol of physical activity.

Figure 2. Percentage of circulating endothelial progenitor cells (immunophenotype CD45neg/CD34pos/CD144pos) and percentage of circulating endothelial microparticles (immunophenotype CD45neg/CD34neg/CD144pos) in all patients with ED at baseline (group A compared to group B).

Figure 2. Percentage of circulating endothelial progenitor cells (immunophenotype CD45neg/CD34pos/CD144pos) and percentage of circulating endothelial microparticles (immunophenotype CD45neg/CD34neg/CD144pos) in all patients with ED at baseline (group A compared to group B).

Figure 3. Percentage of circulating endothelial progenitor cells (immunophenotype CD45neg/CD34pos/CD144pos) and percentage of circulating endothelial microparticles (immunophenotype CD45neg/CD34neg/CD144pos) in all patients with ED after 3 months of PhA standard aerobic protocol (group A compared to group B).

Figure 3. Percentage of circulating endothelial progenitor cells (immunophenotype CD45neg/CD34pos/CD144pos) and percentage of circulating endothelial microparticles (immunophenotype CD45neg/CD34neg/CD144pos) in all patients with ED after 3 months of PhA standard aerobic protocol (group A compared to group B).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.